Losing significant muscle mass lowers your metabolic rate and makes long-term weight maintenance incredibly difficult
These medications carry a boxed warning about thyroid C-cell tumors in rodents, and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
No approved retatrutide dosage exists for routine treatment
Tesamorelin (GHRH analog for visceral fat), MOTS-C (mitochondrial AMPK activation), and BPC-157 (connective tissue support during caloric restriction) are popular adds
Whole-Person Evaluation: Weight, fatigue, hormones, thyroid function, inflammation, pain, sleep, stress, digestion, and recovery can be reviewed together instead of treated as unrelated issues
It maximizes the probability that you will tolerate the full therapeutic dose and maintain it long enough to achieve meaningful results